Robert Charles Breedlove, Principal Accounting Officer at Phathom Pharmaceuticals, Inc. (PHAT), sold 1,692 shares at $8.36 ($14K) on 2025-07-16, disclosed to the SEC on 2025-07-18.
Open-market sale of $14k PHAT by Principal Accounting Officer. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| Filing → |